MIBG Therapy for Pheochromocytomas and Paragangliomas
3 意见
• 07/02/23
0
0
嵌入
Dr. David Mankoff discusses meta-Iodobenzylguanidine (MIBG) therapy, which is a highly targeted therapy for treatment of pheochromocytomas and paragangliomas, at the 2012 Focus on Neuroendocrine Tumors Conference.
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论